Atlas Trials

Impact of OCT1 and CYP2D6 Genotypes on Pharmacokinetics of Berberine in Healthy Volunteers

Clinical trial NCT05463003 · COMPLETED

Trial details

NCT number
NCT05463003
Sponsor
University Medicine Greifswald
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Pharmacokinetic Study in Healthy Volunteers
Start date
2022-07-19
Primary completion
2022-11-20
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.